Last $14.96 USD
Change Today -0.112 / -0.74%
Volume 1.9K
PMD On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

psychemedics corp (PMD) Snapshot

Open
$14.85
Previous Close
$15.07
Day High
$14.96
Day Low
$14.85
52 Week High
02/14/14 - $18.76
52 Week Low
09/16/14 - $12.42
Market Cap
80.4M
Average Volume 10 Days
7.8K
EPS TTM
$0.63
Shares Outstanding
5.4M
EX-Date
11/6/14
P/E TM
23.7x
Dividend
$0.60
Dividend Yield
3.98%
Current Stock Chart for PSYCHEMEDICS CORP (PMD)

Related News

No related news articles were found.

psychemedics corp (PMD) Related Businessweek News

No Related Businessweek News Found

psychemedics corp (PMD) Details

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company’s testing methods utilize a patented technology that focuses on digesting hair and releasing drugs trapped in the hair without destroying the drugs. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, and amphetamines; and opiates, including heroin, hydrocodone, hydromorphone, oxycodone, and codeine. The Company’s tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time. Psychemedics Corporation offers its services to employers for applicant and employee testing; physicians, treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children’s drug use; and Fortune 500 companies and small to mid-size corporations. The company was founded in 1985 and is headquartered in Acton, Massachusetts.

151 Employees
Last Reported Date: 02/28/14
Founded in 1985

psychemedics corp (PMD) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $500.4K
Vice President of Laboratory Operations
Total Annual Compensation: $289.2K
Corporate Vice President of Sales & Marketing
Total Annual Compensation: $235.0K
Compensation as of Fiscal Year 2013.

psychemedics corp (PMD) Key Developments

Psychemedics Announces Quarterly Dividend, Payable on November 20, 2014; Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Psychemedics Corp. also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of November 10, 2014 to be paid on November 20, 2014. The company reported unaudited earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenues of $7,704,047 compared to $7,055,202 a year ago. Operating income was $1,244,211 compared to $1,739,299 a year ago. Net income before provision for income taxes was $1,210,270 compared to $1,739,579 a year ago. Net income and comprehensive income was $916,900 or $0.17 basic and diluted per share compared to $1,052,000 or $0.20 basic and diluted per share a year ago. For the nine months, the company reported revenues of $22,443,005 compared to $20,386,381 a year ago. Operating income was $3,731,971 compared to $4,673,210 a year ago. Net income before provision for income taxes was $3,702,814 compared to $4,765,203 a year ago. Net income and comprehensive income was $2,529,978 or $0.47 per basic and diluted share compared to $2,937,271 or $0.55 per basic and diluted share a year ago.

Psychemedics Corp. Announces Quarterly Dividend, Payable on August 18, 2014; Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Psychemedics Corp. announced a quarterly dividend of $0.15 per share payable to shareholders of record as of August 7, 2014 to be paid on August 18, 2014. The company reported unaudited earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company's revenue was $7.7 million versus $6.9 million for the quarter ended June 30, 2013, an increase of 12%. Net income was $0.857 million or $0.16 per diluted share, versus $1.1 million or $0.20 per diluted share, for the comparable period last year, a decrease of 19%. Operating income was $1.319 million compared with $1.731 million for the same period last year. Net income before provision for income taxes was $1.322 million compared with $1.732 million for the same period last year. For the six months, the company's revenue was $14.7 million versus $13.3 million for the six months ended June 30, 2013, an increase of 11%. Net income was $1.6 million or $0.30 per diluted share, versus $1.9 million or $0.36 per diluted share, for the comparable period last year, a decrease of 14%. Operating income was $2.487 million compared with $2.933 million for the same period last year. Net income before provision for income taxes was $2.492 million compared with $3.025 million for the same period last year.

Psychemedics Corp. Announces Quarterly Dividend Payable on May 19, 2014; Reports Un-Audited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

Psychemedics Corp. announced first quarter financial results for the period ended March 31, 2014. The company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of May 9, 2014 to be paid on May 19, 2014. The company reported un-audited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported revenue of $7.0 million versus $6.4 million for the quarter ended March 31, 2013, an increase of 10%. Net income and comprehensive income was $756,159 or $0.14 per diluted share, versus $822,345 or $0.16 per diluted share, for the comparable period last year.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PMD:US $14.96 USD -0.112

PMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Reference Laboratories Inc $28.43 USD -0.11
Quest Diagnostics Inc $64.43 USD +0.61
View Industry Companies
 

Industry Analysis

PMD

Industry Average

Valuation PMD Industry Range
Price/Earnings 23.6x
Price/Sales 2.8x
Price/Book 6.3x
Price/Cash Flow 23.7x
TEV/Sales 2.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PSYCHEMEDICS CORP, please visit www.psychemedics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.